Blood hexokinase reduction in de novo Parkinson's disease and remodeling of glycolytic energy homeostasis with L-DOPA/Istradefylline combination therapy. (October 2020) - Kanzato, N.; Nakachi, K.; Mochizuki, S.; Kanda, T.; Mori, A.